08:30 AM EDT, 08/12/2026 (MT Newswires) -- Avalyn Pharma ( AVLN ) reported a Q2 net loss Wednesday of $28.9 million, widening from a loss of $20.2 million a year ago.

Two analysts polled by FactSet expected a net loss of $28.6 million.

The company had $413.5 million in cash, cash equivalents and marketable securities as of June 30, with liquidity expected to fund operations into 2029.